119 related articles for article (PubMed ID: 38049937)
1. Neighborhood-level Social Determinants of Health and Waitlist Mortality for Liver Transplantation: The Liver Outcomes and Equity Index.
Zhou K; Lit A; Kuo LS; Thompson LK; Dodge JL; Mehta N; Terrault NA; Ha NB; Cockburn MG
Transplantation; 2024 Jul; 108(7):1558-1569. PubMed ID: 38049937
[TBL] [Abstract][Full Text] [Related]
2. Ethnic and Age Disparities in Outcomes Among Liver Transplant Waitlist Candidates.
Mustian MN; Shelton BA; MacLennan PA; Reed RD; White JA; Eckhoff DE; Locke JE; Allman RM; Gray SH
Transplantation; 2019 Jul; 103(7):1425-1432. PubMed ID: 30418427
[TBL] [Abstract][Full Text] [Related]
3. Exception Policy Change Increased the Simultaneous Kidney-Liver Transplant Probability of Polycystic Disease in the Centers With High Median MELD at Transplantation.
Miyake K; Kim DY; Chau LC; Trudeau S; Kitajima T; Wickramaratne N; Shimada S; Nassar A; Yoshida A; Abouljoud MS; Nagai S
Transplantation; 2024 Jul; 108(7):1632-1640. PubMed ID: 38548699
[TBL] [Abstract][Full Text] [Related]
4. Impact of Acuity Circles on Outcomes for Pediatric Liver Transplant Candidates.
Mogul DB; Perito ER; Wood N; Mazariegos GV; VanDerwerken D; Ibrahim SH; Mohammad S; Valentino PL; Gentry S; Hsu E
Transplantation; 2020 Aug; 104(8):1627-1632. PubMed ID: 32732840
[TBL] [Abstract][Full Text] [Related]
5. Neighborhood-level social determinants of health measures independently predict receipt of living donor liver transplantation in the United States.
Kanneganti M; Byhoff E; Serper M; Olthoff KM; Bittermann T
Liver Transpl; 2024 Jun; 30(6):618-627. PubMed ID: 38100175
[TBL] [Abstract][Full Text] [Related]
6. Effect of Mandatory 6-Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma.
Nagai S; Kitajima T; Yeddula S; Salgia R; Schilke R; Abouljoud MS; Moonka D
Hepatology; 2020 Dec; 72(6):2051-2062. PubMed ID: 32157711
[TBL] [Abstract][Full Text] [Related]
7. Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease?
Bababekov YJ; Hung YC; Chang DC; Rickert CG; Adler JT; Bethea E; Pomfret EA; Pomposelli JJ; Yeh H
Transplantation; 2020 Feb; 104(2):280-284. PubMed ID: 31335769
[TBL] [Abstract][Full Text] [Related]
8. Racial/ethnic disparities in wait-list outcomes are only partly explained by socioeconomic deprivation among children awaiting liver transplantation.
Wadhwani SI; Ge J; Gottlieb L; Lyles C; Beck AF; Bucuvalas J; Neuhaus J; Kotagal U; Lai JC
Hepatology; 2022 Jan; 75(1):115-124. PubMed ID: 34387881
[TBL] [Abstract][Full Text] [Related]
9. Multicenter Study of Age, Frailty, and Waitlist Mortality Among Liver Transplant Candidates.
Haugen CE; McAdams-DeMarco M; Holscher CM; Ying H; Gurakar AO; Garonzik-Wang J; Cameron AM; Segev DL; Lai JC
Ann Surg; 2020 Jun; 271(6):1132-1136. PubMed ID: 30672803
[TBL] [Abstract][Full Text] [Related]
10. Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
Yi Z; Mayorga ME; Orman ES; Wheeler SB; Hayashi PH; Barritt AS
Transplantation; 2017 Oct; 101(10):2368-2374. PubMed ID: 28858174
[TBL] [Abstract][Full Text] [Related]
11. Where you live matters: Area deprivation predicts poor survival and liver transplant waitlisting.
Hasjim BJ; Huang AA; Paukner M; Polineni P; Harris A; Mohammadi M; Kershaw KN; Banea T; VanWagner LB; Zhao L; Mehrotra S; Ladner DP
Am J Transplant; 2024 May; 24(5):803-817. PubMed ID: 38346498
[TBL] [Abstract][Full Text] [Related]
12. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
13. Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients.
Ross K; Patzer RE; Goldberg DS; Lynch RJ
Am J Transplant; 2017 Nov; 17(11):2879-2889. PubMed ID: 28695615
[TBL] [Abstract][Full Text] [Related]
14. Racial-ethnic differences in liver transplant waitlist outcomes in patients with hepatocellular carcinoma before and after recent changes to allocation policy.
Mazur RD; Cron DC; Goldberg DS; Yeh H; Dageforde LA
Clin Transplant; 2024 Jun; 38(6):e15365. PubMed ID: 38804605
[TBL] [Abstract][Full Text] [Related]
15. A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
Mehta N; Dodge JL; Roberts JP; Yao FY
J Hepatol; 2021 Apr; 74(4):829-837. PubMed ID: 33188904
[TBL] [Abstract][Full Text] [Related]
16. Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics.
Thuluvath PJ; Amjad W; Zhang T
PLoS One; 2020; 15(12):e0244744. PubMed ID: 33382811
[TBL] [Abstract][Full Text] [Related]
17. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
[TBL] [Abstract][Full Text] [Related]
18. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
[TBL] [Abstract][Full Text] [Related]
19. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
